- Home
- GLBS vs AKTX Comparison
GLBS vs AKTX Comparison
Compare GLBS & AKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GLBS
- AKTX
- Stock Information
- Founded
- GLBS 2006
- AKTX N/A
- Country
- GLBS Greece
- AKTX United States
- Employees
- GLBS N/A
- AKTX N/A
- Industry
- GLBS Marine Transportation
- AKTX Biotechnology: Pharmaceutical Preparations
- Sector
- GLBS Consumer Discretionary
- AKTX Health Care
- Exchange
- GLBS Nasdaq
- AKTX Nasdaq
- Market Cap
- GLBS 25.9M
- AKTX 29.5M
- IPO Year
- GLBS 2007
- AKTX N/A
- Fundamental
- Price
- GLBS $1.07
- AKTX $0.99
- Analyst Decision
- GLBS
- AKTX
- Analyst Count
- GLBS 0
- AKTX 0
- Target Price
- GLBS N/A
- AKTX N/A
- AVG Volume (30 Days)
- GLBS 58.0K
- AKTX 80.4K
- Earning Date
- GLBS 11-29-2024
- AKTX 02-15-2025
- Dividend Yield
- GLBS N/A
- AKTX N/A
- EPS Growth
- GLBS 61.29
- AKTX N/A
- EPS
- GLBS 0.14
- AKTX N/A
- Revenue
- GLBS $33,289,000.00
- AKTX N/A
- Revenue This Year
- GLBS $15.39
- AKTX N/A
- Revenue Next Year
- GLBS $43.34
- AKTX N/A
- P/E Ratio
- GLBS $8.14
- AKTX N/A
- Revenue Growth
- GLBS 2.74
- AKTX N/A
- 52 Week Low
- GLBS $1.06
- AKTX $0.90
- 52 Week High
- GLBS $3.15
- AKTX $4.40
- Technical
- Relative Strength Index (RSI)
- GLBS 28.49
- AKTX 31.38
- Support Level
- GLBS $1.10
- AKTX $0.95
- Resistance Level
- GLBS $1.39
- AKTX $1.13
- Average True Range (ATR)
- GLBS 0.10
- AKTX 0.15
- MACD
- GLBS -0.02
- AKTX 0.02
- Stochastic Oscillator
- GLBS 5.74
- AKTX 15.15
About GLBS Globus Maritime Limited
Globus Maritime Ltd is a dry bulk shipping company that provides marine transportation services internationally. The company owns, operates, and manages a fleet of dry bulk vessels that transport iron ore, coal, grain, steel products, cement, alumina, and other dry bulk cargo. Its operations are managed by its subsidiary which also provides in-house commercial and technical management for its vessels and also offers consulting services for an affiliated ship management company. It generates maximum revenues by charging customers for the use of vessels to transport dry bulk commodities.
About AKTX Akari Therapeutics plc ADS
Akari Therapeutics PLC is a clinical stage biopharmaceutical company. It is focused on developing therapies for autoimmune and inflammatory diseases involving the complement component 5 (C5) and leukotriene B4 (LTB4) pathways. The company's pipelines include HSCT-TMA and Geographic Atrophy (GA).